Hero

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call

About Celyad

Making the Impossible Possible

Celyad is a clinical-stage biopharmaceutical that is developing next generation CAR-T NK cell-based immunotherapies for cancer treatment.

Latest News

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call

Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates

Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates

Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City

Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City

Discover all news

Carousel

Social Feed

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call $CYAD #conferencecall #investors… https://t.co/BnuAD81DkP

1 day ago

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call $CYAD #conferencecall #investors… https://t.co/BnuAD81DkP

Today: David Gilham, VP R&D at @CelyadSA presented our shRNA platform and in particular the results in allogeneic s… https://t.co/kSgfr7QwFM

2 days ago

Today: David Gilham, VP R&D at @CelyadSA presented our shRNA platform and in particular the results in allogeneic s… https://t.co/kSgfr7QwFM

In case you miss it: @CelyadSA organized an R&D Day at Nasdaq Market site this monday! Watch the webcast video… https://t.co/yh8QQvnx38

2 days ago

In case you miss it: @CelyadSA organized an R&D Day at Nasdaq Market site this monday! Watch the webcast video… https://t.co/yh8QQvnx38

@ChristianHomsy https://t.co/LQhiyR3qSy

3 days ago

@ChristianHomsy https://t.co/LQhiyR3qSy

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call $CYAD #conferencecall #investors… https://t.co/BnuAD81DkP

1 day ago

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call $CYAD #conferencecall #investors… https://t.co/BnuAD81DkP

Today: David Gilham, VP R&D at @CelyadSA presented our shRNA platform and in particular the results in allogeneic s… https://t.co/kSgfr7QwFM

2 days ago

Today: David Gilham, VP R&D at @CelyadSA presented our shRNA platform and in particular the results in allogeneic s… https://t.co/kSgfr7QwFM

In case you miss it: @CelyadSA organized an R&D Day at Nasdaq Market site this monday! Watch the webcast video… https://t.co/yh8QQvnx38

2 days ago

In case you miss it: @CelyadSA organized an R&D Day at Nasdaq Market site this monday! Watch the webcast video… https://t.co/yh8QQvnx38

@ChristianHomsy https://t.co/LQhiyR3qSy

3 days ago

@ChristianHomsy https://t.co/LQhiyR3qSy